Annual Grant Award Dollars
| Investigator | Title | Sponsor | ID | Dates | Amount |
| Abhishek Singh | Molecular mechanisms controlling | American Society of Hematology | ASH_SINGH | 7/1/2020-6/30/2021 | $33,334 |
| Andrew Volk, PhD | The role of CHAF1B in maintaining the undifferentiated state of myeloid leukemic stem cells | The Leukemia and Lymphoma Society | LLS, Volk, A. | 7/1/2020-6/30/2021 | $67,000 |
| Andrew Volk, PhD | The Role of Chromatin Assembly in Down Syndrome-related Acute Megakaryoblastic Leukemia | Ohio Cancer Research Associates | Volk, A. OCR | 7/1/2020-6/30/2021 | $30,000 |
| Benjamin E Tourdot, PhD | The Racial Disparity in platelet PAR4 signaling enhances thrombus formation | National Heart, Lung & Blood Institute National Institues of Health (NIH) | R00HL136784 | 4/1/2021-3/31/2022 | $249,000 |
| Damien Reynaud, PhD | Normal and Pathological Hematopoietic stem cells in obesity | National Heart, Lung & Blood Institute National Institues of Health (NIH) | R01HL141418 | 4/1/2021-3/31/2022 | $397,500 |
| Daniel Lucas, PhD | Cellular crosstalk in the hematopoietic microenvironment | National Heart, Lung & Blood Institute National Institues of Health (NIH) | R01HL136529 | 5/1/2021-4/30/2022 | $394,381 |
| Daniel T. Starczynowski, PhD | Decoding inate immune signaling in normal and myeloidysplastic hematopoiesis | National Heart, Lung & Blood Institute National Institues of Health (NIH) | R35HL135787 | 1/1/2021-12/31/2021 | $737,482 |
| Daniel T. Starczynowski, PhD | Rational therapeutic targeting of oncogenic immune signaling states in myeloid malignancies | The Leukemia and Lymphoma Society | 8021-20 | 4/1/2021-3/31/2022 | $250,000 |
| Daniel T. Starczynowski, PhD | Exploring the contribution of the microbiome to the pathogenesis of myelodysplastic syndromes | Edward P. Evans Foundation | Starczynowski, D., E | 9/1/2020-8/31/2021 | $200,000 |
| Daniel T. Starczynowski, PhD Mohammad Azam, PhD |
Azam NIH 12 2019 | National Cancer Institute National Institues of Health (NIH) | R01CA250516 | 7/1/2020-6/30/2021 | $244,207.50 |
| Dao Pan, PhD | Manipulation of microRNA for CNS delivery: implication to treatment of neurological LSD | Ntl Inst of Neuro Disorders & Stroke National Institues of Health (NIH) | R56NS114124 | 9/15/2020-8/31/2021 | $555,040 |
| Elisa Boscolo, PhD | Venous Malformations (VM): A Murine Model to Identify Therapies to Target Aberrant Venous Development | National Heart, Lung & Blood Institute National Institues of Health (NIH) | R01HL117952 | 2/15/2021-1/31/2022 | $572,400 |
| James Mulloy, PhD | Instructive role of MLL fusion proteins in lineage deter | The University of Chicago (National Cancer Institute) National Institues of Health (NIH) | R01CA215504 | 3/1/2020-2/28/2022 | $708,554 |
| James Mulloy, PhD | the role of Hedgehog signaling in gastric tissue repair and regeneration | University of Arizona (National Institutes of Health) National Institues of Health (NIH) | 567639 | 11/1/2019-4/30/2021 | $23,023 |
| James Mulloy, PhD Yi Zheng, PhD |
Leukemia Stem Cell Polarity and Differentiation therapy | National Cancer Institute National Institues of Health (NIH) | R01CA204895 | 8/1/2020-7/31/2021 | $442,805 |
| Jay Pundavela, PhD | Immune-Schwann Cell Signaling in Neurofibroma Development | Department of Defense Army | W81XWH2010116 | 4/1/2021-3/31/2022 | $159,000 |
| Jennifer PatrittiCram | Understanding the role of purinerigic signaling on tumor formation in a mouse of NF-1 | The Children's Tumor Foundation | 2020-01-006 | 7/1/2020-6/30/2021 | $32,000 |
| Jianqiang Wu, MD | miR-155 and RUNX function in neurofibroma tumorigenesis | Ntl Inst of Neuro Disorders & Stroke National Institues of Health (NIH) | R01NS097233 | 7/1/2020-6/30/2022 | $341,250 |
| Jianqiang Wu, MD Nancy Ratner, PhD |
Targeting Complement 5a-Mediated Immunoregulation for Neurofibroma Therapy | Ntl Inst of Neuro Disorders & Stroke National Institues of Health (NIH) | R33NS112407 | 5/1/2021-2/28/2022 | $397,451 |
| John E Robinson | Leveraging systemic AAV vectors to ameliorate autistic phenotypes in neurofibromatosis type 1,” to the SFARI Bridge to Independence RFA. | Simons Foundation | 663007 | 1/1/2021-12/31/2021 | $165,000 |
| Jose Cancelas-Perez, MD, PhD | Mitochondria mediated intercellular metabolic coupling in bone marrow | Ntl Inst of Diab & Digest & Kidney Dis National Institues of Health (NIH) | R01DK124115 | 7/1/2020-4/30/2021 | $279,840 |
| Jose Cancelas-Perez, MD, PhD | Disseminating Curative Biological Therapies for Rare Ped | Children's Hospital Boston (Natl. Ctr for Advancing Translational Sc)National Institues of Health (NIH) | U01TR001814 | 7/1/2020-6/30/2021 | $166,838 |
| Kalen P Berry, PhD | Berry NIH-UC T32 | University of Cincinnati (National Cancer Institute) National Institues of Health (NIH) | 1014415 | 9/1/2020-8/31/2021 | $50,376 |
| Kalen P Berry, PhD | Targeting Neuronal Activity for Treating Pediatric Malignant Brain Tumors | Cancer Free Kids | CFK Berry | 12/30/2020-12/30/2021 | $50,000 |
| Lai Man Wu, PhD | Identification of Cellular heterogeneity and oncogenic networks in MPNST by single cell transcriptomics and epigenomics for targeted therapy | Department of Defense Army | W81XWH2010443 | 6/1/2020-5/31/2021 | $79,500 |
| Lai Man Wu, PhD | Identification of cellular heterogeneity and tumor-initiating cells driving NF-to-MPNST by single-cell multi-omics for targeted therapy | Pablove Foundation | Wu, Pablove Fdn. | 7/1/2020-6/30/2021 | $52,500 |
| Leah J Kershner | Kershner T32-UC 2018 | University of Cincinnati (National Cancer Institute) National Institues of Health (NIH) | 1014415 | 9/1/2020-8/31/2021 | $53,460 |
| LEI HUANG, MD | Defining neuron- and microglia-specific contributions to prefrontal cortex dysfunction in chronic stress | University of Cincinnati (National Institutes of Health) National Institues of Health (NIH) | 012928-002 | 5/6/2020-2/28/2021 | $46,444 |
| LEI HUANG, MD | Evaluating the Therapeutic Potential of Cardiac Glycosides Against Medulloblastoma | Department of Defense Army | W81XWH2010870 | 9/1/2020-8/31/2021 | $190,787 |
| LEI HUANG, MD | Evaluating an orally active proteasome inhibitor, CEP-18770, in the treatment of primary and recurrent medulloblastoma | Cancer Free Kids | CEP-18770 | 1/1/2021-12/30/2021 | $50,000 |
| LEI HUANG, MD | Identification of causal factors underlying cognitive deficits in a mouse model of childhood leukemia survival | University of Cincinnati (National Institute of Nursing Research) National Institues of Health (NIH) | 013249-002 | 9/7/2020-6/30/2021 | $55,230 |
| Marie-Dominique Filippi, PhD | The Role Of Mitochondria In Bone Marrow Failure | Department of Defense Army | W81XWH2010689 | 8/1/2020-7/30/2021 | $254,505 |
| Marie-Dominique Filippi, PhD | Filippi VA 2019 | Cincinnati Veterans Administration | VA, Filippi, M. | 9/1/2020-8/31/2021 | $6,645 |
| Marie-Dominique Filippi, PhD | The Role of Mitocondria in hematopoietic stem cell self-renewal | National Heart, Lung & Blood Institute National Institues of Health (NIH) | RHL151654A | 1/1/2021-12/31/2021 | $553,593 |
| Marie-Dominique Filippi, PhD Harry Leighton Grimes, PhD |
Regulation of functionally discrete hematopietic s | Ntl Inst of Diab & Digest & Kidney Dis National Institues of Health (NIH) | R01DK121062 | 1/1/2021-12/31/2021 | $264,219.50 |
| Mark Wunderlich | Therapeutic insights through patient derived leukemia xe | National Cancer Institute National Institues of Health (NIH) | R50CA211404 | 9/1/2020-8/31/2021 | $172,232 |
| Mark Wunderlich | Development and Testing of CAR-NK Cells for Relapsed Pediatric Acute Myeloid Leukemia | Cancer Free Kids | CFK, Wunderlich | 12/31/2020-12/30/2021 | $50,000 |
| Md Nasimuzzaman, PhD | Role of PAR in organ dysfunctions and pathologies of sickle cell anemia | American Society of Hematology | Nasimuzzaman, MD, AS | 3/1/2021-2/28/2022 | $150,000 |
| Mei Xin, PhD Richard Lang, PhD |
Light and hyaloid Hippo | National Eye Institute National Institues of Health (NIH) | R01EY032029 | 1/1/2021-12/31/2021 | $173,393 |
| Nancy Ratner, PhD | Mitogenic Activities in Neurofibromatosis | Ntl Inst of Neuro Disorders & Stroke National Institues of Health (NIH) | R01NS028440 | 7/1/2020-6/30/2021 | $445,976 |
| Nancy Ratner, PhD | Single cell analyses of NF1 Plexiform Neurofibroma and Atypical Neurofibroma in Human and and in Mouse Models | Department of Defense | W81XWH1910816 | 9/30/2020-9/29/2021 | $290,052 |
| Nicolas Nassar, PhD Jose Cancelas-Perez, MD, PhD |
Targeted Inhibition in Leukemia | National Cancer Institute National Institues of Health (NIH) | R01CA237016 | 7/8/2020-6/30/2021 | $502,536 |
| Oluwabukola T Gbotosho, PhD | Role of macrophages in inflammation and hemin-induced acute chest syndrome in sickle cell disease | American Society of Hematology | Gbotosho, O., ASH | 7/1/2020-6/30/2021 | $50,000 |
| Paul Andreassen, PhD | DNA Damage Response Pathways in Meiotic Sex Chromosome Inactivation | University of California-Davis (Ntl Inst of General Medicine Sciences) National Institutes of Health (NIH) | A21-2844-S001 | 11/1/2020-1/31/2021 | $7,041 |
| Punam Malik, MD | Reducing Error-Prone Repair for Therapeutic correction of sickle cell anemia | Doris Duke Charitable Foundation | DorisDukes - Punam,M | 9/1/2020-8/31/2021 | $330,000 |
| Punam Malik, MD | Reducing Error-Prone Repair for Therapeutic correction of sickle cell anemia-Supplement | Doris Duke Charitable Foundation | 2019114A | 2/1/2021-1/31/2022 | $137,500 |
| Puneet Agarwal, PhD | Role of gut microbial signals on treatment-resistant AML cells | Cancer Free Kids | CFK Agarwal | 1/1/2021-12/31/2021 | $50,000 |
| Puneet Agarwal, PhD | Investigating the role of microbial products on the progression of hematologic malignancies | The Ohio State University Research Fnd | OSU, Agarwal | 3/1/2021-2/28/2022 | $74,578 |
| Qing Richard Lu, PhD | Therapeutic targeting of a novel tumor suppressor in aggressive medulloblastoma | Team Connor Childhood Cancer Foundation | Lu, Qing, TCCCF | 1/1/2021-12/31/2021 | $100,000 |
| Qing Richard Lu, PhD | Novel effective proton beam delivery system to target malignant medulloblastoma in animal models | Pray Hope Believe Foundation | Lu, PHBF | 1/1/2021-12/31/2021 | $100,000 |
| Ronald R Waclaw, PhD Kenneth J Campbell, PhD |
Campbell Resub R01MH090740 | National Institute of Mental Health National Institues of Health (NIH) | 2R01MH090740 | 5/1/2021-4/30/2022 | $289,417 |
| Ruhikanta Amom Meetei, PhD | A Novel FANCD2-Chromatin Bound Complex in Replication Stress Response and HSC Maintenance | Department of Defense Army | W81XWH1910262 | 7/1/2020-6/30/2021 | $258,372 |
| Sandra Schrenk, PhD | Semaphorin 3A and 3F in TIE2-mutated Venous Malformation | American Heart Association - National | 833891 | 5/1/2021-4/30/2022 | $69,446 |
| Timothy M Chlon, PhD | The Role of DDX41 in Inherited Myelodysplastic Syndromes | Ntl Inst of Diab & Digest & Kidney Dis National Institues of Health (NIH) | K01DK121733 | 8/1/2020-7/31/2021 | $107,995 |
| Timothy M Chlon, PhD | Modeling DDX41-mutated Myelosdysplastic Syndromes to Identify Therapeutic Vulnerability | Edward P. Evans Foundation | Chlon, Tim, EPEF | 7/1/2020-6/30/2021 | $125,000 |
| Vishnu M Modur, PhD | PRC2 in maintaining an immunologically ‘cold’ microenvironment in Diffuse Intrinsic Pontine Glioma (DIPG) Tumors | Cancer Free Kids | CFK, Modur | 12/30/2020-12/31/2021 | $50,000 |
| Yi Zheng, PhD | Targeting TET1 signaling to treat acute myeloid leukemia | City of Hope (National Cancer Institute) National Institues of Health (NIH) | R01CA211614 | 1/1/2021-12/31/2021 | $68,640 |
| Yi Zheng, PhD | Treating Fanconi Anemia Cancer | Fanconi Anemia Research Fund | FARF 2019 Zheng | 11/1/2020-10/31/2021 | $100,000 |
| Yi Zheng, PhD | Novel mechanism of intestinal stem cell aging | National Institute on Aging National Institues of Health (NIH) | R01AG063967 | 9/15/2020-5/31/2021 | $505,734 |
| Yi Zheng, PhD | Rational Targeting Oncogenic Kras and Sos Interaction in JMML | University of Wisconsin-Madison (Department of Defense Army) | 812 | 8/1/2020-7/31/2021 | $160,000 |
| Yi Zheng, PhD Jose Cancelas-Perez, MD, PhD |
Small molecules targeting RhoA for platelet cold storage in cancer care | National Heart, Lung & Blood Institute National Institues of Health (NIH) | R01HL147536 | 3/1/2021-2/28/2022 | $560,172 |
| Total Annual Grant Award Dollars | $13,081,449 | ||||
Annual Industry Award Dollars
| Investigator | Industry Sponsor | Amount |
| Daniel T. Starczynowski, PhD | Kurome Therapetics | $107,187 |
| John P Perentesis, MD | Varian Medical Systems, Inc. | $568,924 |
| Nicolas Nassar, PhD | Sanofi Synthelabo | $125,000 |
| Qing Richard Lu, PhD | Sanofi Synthelabo | $125,000 |
| Total Annual Industry Award Dollars | $926,111 | |
